Open AccessThe effect of aripiprazole on leptin levels of patients with chronic schizophrenia and a comparison of leptin, acute phase protein, and cytokine levels with regard to body mass and body composition indexes
Author(s) -
Jarosław Sobiś,
Łukasz Kunert,
Monika Rykaczewska-Czerwińska,
Elżbieta Świętochowska,
Piotr Gorczyca
Publication year - 2022
Publication title -
endokrynologia polska
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.413
H-Index - 27
eISSN - 2299-8306
pISSN - 0423-104X
DOI - 10.5603/ep.a2021.0110
Subject(s) - leptin , medicine , endocrinology , body mass index , insulin , acute phase protein , serum amyloid a , aripiprazole , waist , obesity , tumor necrosis factor alpha , schizophrenia (object oriented programming) , inflammation , psychiatry
The aim of this study was to test the effect of aripiprazole on leptin, insulin, acute phase proteins, and selected cytokines levels in patients with chronic schizophrenia. Additionally, levels of leptin, insulin, acute phase proteins, and cytokines were compared with body mass and body composition indexes.